Pulmonary Disease
Signs Physical
and Assessm
Pathophysio
Sympto ent Pharmacologic
logy
ms Findings Recommendations
Summary
(subject (objecti
ive) ve)
COPD is a Emphyse Emphyse Emphysema: Non-
general term for ma: ma: Barrel pharmacological
chronic dyspnea, chest, interventions: Smoking
respiratory hyperventil clubbed cessation, avoidance of
disorders that are ation, fingers, respiratory irritants,
described by fatigue weight loss, Pursed-lip breathing
progressive chest x-ray Pharmacological
tissue and interventions:
degeneration and Chronic pulmonary Bronchodilators such as
obstruction in the Bronchitis function short acting B2 agonists
airways of the : constant tests and anticholinergic agents
lungs. (Hubert & productive indicate are the two main
VanMeter, 2018, cough, presence of medications used during
p. 302). COPD shortness increased exacerbations. (Qureshi et.
causes damage of breath, residual al, 2014). Combination
to the lungs and weight loss volume and drug albuterol-ipratropium
can have total lung inhaler acts as a
irreversible long capacity bronchodilator and reduces
term effects. Bronchiec with bronchospasm.
This study source was downloaded by 100000829957125 from CourseHero.com on 01-31-2022 07:41:16 GMT -06:00
https://www.coursehero.com/file/47245692/NR499-Week4-DBdocx/